Healthcare & Pharmaceutical Awards 2021

26 GHP / Healthcare and Pharmaceutical Awards 2021 , Jul21364 Experienced in advanced eye laser systems and safe treatment planning, combined with high precision diagnostic instruments, SCHWIND Eye Tech Solutions GmbH is leading the way in the eye surgery industry. We find out more about the firm and its revolutionary procedures. Best Refractive Eye Surgery Technology Specialists 2021 SCHWIND Eye- Tech-Solutions is one of the technology leaders for laser eye surgery for refractive and therapeutic corneal issues. The family business develops, produces, and markets a comprehensive product portfolio for the treatment of vision defects and corneal diseases. Headquartered near Aschaffenburg, Germany, the firm employs 150 people, including eye surgeons in more than 100 countries treating their patients with SCHWIND technologies. To date, about 2,000 SCHWIND laser systems have already been installed worldwide. With SCHWIND AMARIS excimer laser product family and SCHWIND ATOS femtosecond laser, the company covers the most important all-laser procedures of modern refractive corneal surgery, including touch free TransPRK and SmartSurfACE surface treatment, intrastromal FemtoLASIK and minimally invasive SmartSight lenticule extraction procedures. The SCHWIND ATOS femtosecond laser is the latest laser development from SCHWIND and enables lenticule extraction (SmartSight) as well as flap creation in Femtolasik. The system expands the platforms available in refractive surgery with up-to-date technology, sophisticated safety concepts and a new design. Featuring intelligent eye tracking with pupil recognition and cyclotorsion compensation, the laser system provides precise centering of the patient’s eye along the visual axis. The shape of the innovative patient interface follows the corneal limbus and not only provides a good fit, but also reduces pressure on the eye. Whether lenticules or flaps, ATOS provides a homogenous surface, making SmartSight lenticule extraction simple and allowing the flap to be easily lifted in Femtolasik. ATOS features trim dimensions and a small footprint for flexible use. Against the backdrop of continual innovation, SCHWIND faces, as other medical device manufacturers, unique challenges to comply with significant regulatory changes under the European Union’s new Medical Devices Regulation (MDR). Much greater emphasis has been placed on clinical data, clinical evaluations, and post-market surveillance and this must be reflected in the technical documentation and quality management system. SCHWIND has developed and realized a regulatory strategy to seize the opportunity to streamline business processes and data management for improved compliance, stronger collaboration, and even greater efficiency. So far, the firm’s most significant success has been the development and further development of SCHWIND AMARIS excimer laser technology. At its introduction in 2007, the SCHWIND AMARIS excimer laser quickly established itself as the market pacesetter, and it has been continuously refined since then. With pulse rates up to 1050 hertz and eye tracking that actively compensates for eye movement in up to seven dimensions of space and time, the three AMARIS models rank among the leading technologies. The benefits of the SCHWIND AMARIS technology include a uniquely broad range of applications. SCHWIND is also a pioneer in treatment methods with its touch- free SmartSurfACE technology, PresbyMAX planning tool for presbyopia treatment, and KPL function for planning and performing corneal transplants. More than 7.5 million treatments have been performed with AMARIS technology so far. Additionally, more than 250 peer-reviewed articles published by AMARIS users reflect the success story of the SCHWIND excimer laser product family. More recently, SCHWIND was bestowed with the prestigious accolade of Best Refractive Eye Surgery Technology Specialists 2021 in the Healthcare and Pharmaceutical Awards 2021. SCHWIND is committed to giving surgeons the best possible tools to work with which is why the company continues to work on improvements, additional applications, and a larger product portfolio to support surgeons with appropriate solutions for human cornea treatment. The SCHWIND ATOS femtosecond laser platform provides versatile possibilities for integrating additional features and applications in the future. Moreover, excimer laser technology will be further developed. Regarding the future for SCHWIND, the aim is simple: to further improve the surgical experience and, ultimately, to improve patients’ vision and quality of life. Contact: Domenic von Planta, COO Company: SCHWIND eye-tech- solutions GmbH Web: